
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Entero Healthcare Solutions Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.

Price Band
₹1,258
Per Share
Lot Size
11 Shares

Minimum Investment
₹13,838

Issue Size
₹1,600 Cr

Face Value
₹10
Per Share
IPO Type
Book Building

Retail Quota
10%

QIB Quota
75%

NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
77.11%
Issue Type
Book Building
ISIN
INE010601016
The Company's primary line of business is in the distribution of healthcare products to retail pharmacies, hospitals and healthcare clinics in India. The Company adds value to the healthcare product manufacturers that work with it by providing them reach and accessibility to pharmacies, hospitals and clinics through its integrated and technology driven, pan-India healthcare products distribution platform. As of September 30, 2023, its 77 warehouses located across the country, last-mile delivery infrastructure and relationships with pharmacies, hospitals and clinics enables healthcare product manufacturers to make their products available to a wide range of customers.
The target addressable market for pharmaceutical distributors in India is valued at Rs. 2.7 trillion in the Financial Year 2023 and is expected to grow at 10% to 11% CAGR from the Financial Year 2023 to the Financial Year 2028. The distribution of pharmaceutical products in India is extremely fragmented with approximately 65,000 distributors, as of March 31, 2023, that generally service limited local areas only, unlike developed markets where large nationwide distributors occupy a dominant market position. In the Indian pharmaceutical distribution market, traditional local distributors have a 90-92% market share while large/national distributors have a 8-10% market share.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offering of 12,725,244# equity shares of face value of Rs. 10 each ("Equity") of Entero Healthcare Solutions Limited (The "Company" or the "Issuer") for cash at a price of Rs. 1,258 per equity share including a share premium of Rs. 1,248 per equity share (the "Offer Price") aggregating to Rs. 1600.00# crores (the "Offer"). The offer comprises of a fresh issue of 7,955,769# equity shares by the company aggregating to Rs. 1000.00# crores (the "Fresh Issue") and an offer for sale of 4,769,475# equity shares (the "Offered Shares") aggregating to Rs. 600.00# crores (the "Offer for Sale"), comprising of 470,210# equity shares aggregating to Rs. 59.15# crores by Prabhat Agrawal, 313,472# equity shares aggregating to Rs. 39.44# crores by Prem Sethi, 3,815,580# equity shares aggregating to Rs. 480.00# crores by Orbimed Asia iii Mauritius Limited, 4,401# equity shares aggregating to Rs. 0.55# crores by Chethan M.P., 1,320# equity shares aggregating to Rs. 0.17# crores by Deepesh T. Gala, 8,802# equity shares aggregating to Rs. 1.11# crores by Hemant Jose Barros, 4,401# equity shares aggregating to Rs. 0.55# crores by Hemant Jaggi, 2,201# equity shares aggregating to Rs. 0.28# crores by K.R.V.S. Varaprasad, 39,610# equity shares aggregating to Rs. 4.98# crores by K.E. Prakash, 1,320# equity shares aggregating to Rs. 0.17# crores by Lavu Sahadev, 12,103# equity shares aggregating to Rs. 1.52# crores by Manoj K Sanghani, 8,802# equity shares aggregating to Rs. 1.11# crores by Millennium Medicare Private Limited, 2,201# equity shares aggregating to Rs. 0.28# crores by K. Naveen Kumar Gupta, 42,250# equity shares aggregating to Rs. 5.32# crores by Novacare Drug Specialities Private Limited, 15,074# equity shares aggregating to Rs. 1.90# crores by Petros Diamantides, 13,203# equity shares aggregating to Rs. 1.66# crores by Prashanth Ravindrakumar, 1,102# equity shares aggregating to Rs. 0.14# crores by Suraj Prakash Atreja, 1,320# equity shares aggregating to Rs. 0.17# crores by Venkata Ramana Siva Kumar Yanamadala, 12,103# equity shares aggregating to Rs. 1.52# crores by Vikramaditya Ambre (collectively the "Selling Shareholders") (the "Offer for Sale, and together with the fresh issue, the "Offer"). The offer will constitute 29.25%# of the post-offer paid-up equity share capital of the company. The offer included a reservation of 70,237# equity shares, aggregating to Rs. 8.00# crores (constituting 0.16%# of the post-offer paid-up equity share capital), for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer constitute 29.25%# and 29.09%#, respectively, of the post-offer paid-up equity share capital of the company. The company, in consultation with the book running lead managers, offered a discount of 9.46% to the offer price to eligible employees bidding in the employee reservation portion ("Employee Discount"). #Subject to finalisation of basis of allotment The face value of equity shares is Rs. 10 each. The offer price is 125.80 times the face value of the equity shares.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Entero Healthcare Solutions Limited was incorporated as "Entero Healthcare Solutions Private Limited" as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Thereafter, the Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of its Shareholders held on August 7, 2023, and consequently, the name of the Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.
Wholesalers and Retailers
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
*Subject to approvals and market conditions.